Caplin Point Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Audited financial results of the Company for the year ended March 31, 2026 (both Standalone & Consolidated) and declaration of Interim Dividend, if any, for the FY 2025-26